Mercuri, Nicola Biagio

Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta

Lacey, M. G., Mercuri, N. B., & North, R. A. (1987) · The Journal of Physiology

Ion channel regulation and functionNeuroscience and Neuropharmacology Research

Cited by 614

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease

Nobili, A., Latagliata, E. C., Viscomi, M. T., Cavallucci, V., Cutuli, D., Giacovazzo, G., Krashia, P., Rizzo, F. R., Marino, R., Federici, M., et al. (2017) · Nature Communications

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 514

Dysbiosis of gut microbiota in a selected population of Parkinson's patients

Pietrucci, D., Cerroni, R., Unida, V., Farcomeni, A., Pierantozzi, M., Mercuri, N. B., Biocca, S., Stefani, A., & Desideri, A. (2019) · Parkinsonism & Related Disorders

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 217

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection

Liguori, C., Pierantozzi, M., Spanetta, M., Sarmati, L., Cesta, N., Iannetta, M., Ora, J., Mina, G. G., Puxeddu, E., Balbi, O., et al. (2020) · Brain, Behavior, and Immunity

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 212

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., et al. (2019) · Nature Communications

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 188

Exercise interventions in Alzheimer’s disease: A systematic review and meta-analysis of randomized controlled trials

López-Ortiz, S., Valenzuela, P. L., Seisdedos, M. M., Morales, J. S., Vega, T., Castillo-García, A., Nisticò, R., Mercuri, N. B., Lista, S., Lucia, A., et al. (2021) · Ageing Research Reviews

Dementia and Cognitive Impairment ResearchPhysical Activity and Health

Cited by 152

Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease

La Barbera, L., Vedele, F., Nobili, A., Krashia, P., Spoleti, E., Latagliata, E. C., Cutuli, D., Cauzzi, E., Marino, R., Viscomi, M. T., et al. (2021) · Progress in Neurobiology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 98

Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?

Costa, C., Parnetti, L., D'Amelio, M., Tozzi, A., Tantucci, M., Romigi, A., Siliquini, S., Cavallucci, V., Di Filippo, M., Mazzocchetti, P., et al. (2016) · Neurobiology of Aging

Epilepsy research and treatmentAlzheimer's disease research and treatments

Cited by 94

In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer’s disease

Serra, L., D'Amelio, M., Di Domenico, C., Dipasquale, O., Marra, C., Mercuri, N. B., Caltagirone, C., Cercignani, M., & Bozzali, M. (2018) · Neurobiology of Aging

Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research

Cited by 91

The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area

Mercuri, N. B., Calabresi, P., & Bernardi, G. (1992) · Life Sciences

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 86

Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer’s disease

Cordella, A., Krashia, P., Nobili, A., Pignataro, A., La Barbera, L., Viscomi, M. T., Valzania, A., Keller, F., Ammassari-Teule, M., Mercuri, N. B., et al. (2018) · Neurobiology of Disease

Alzheimer's disease research and treatmentsMemory and Neural Mechanisms

Cited by 82

On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area

Krashia, P., Martini, A., Nobili, A., Aversa, D., D'Amelio, M., Berretta, N., Guatteo, E., & Mercuri, N. B. (2017) · European Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 61

Actions of methylphenidate on dopaminergic neurons of the ventral midbrain

Federici, M., Geracitano, R., Bernardi, G., & Mercuri, N. B. (2005) · Biological Psychiatry

Neurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity Disorder

Cited by 48

Sex hormones differentially contribute to Parkinson disease in males: A multimodal biomarker study

Bovenzi, R., Sancesario, G. M., Conti, M., Grillo, P., Cerroni, R., Bissacco, J., Forti, P., Giannella, E., Pieri, M., Minosse, S., et al. (2023) · European Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 41

Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients

Liguori, C., Olivola, E., Pierantozzi, M., Cerroni, R., Galati, S., Saviozzi, V., Mercuri, N. B., & Stefani, A. (2017) · CNS & Neurological Disorders - Drug Targets

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 20

miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network

Pulcrano, S., De Gregorio, R., De Sanctis, C., Volpicelli, F., Piscitelli, R. M., Speranza, L., Perrone-Capano, C., di Porzio, U., Caiazzo, M., Martini, A., et al. (2023) · The Journal of Neuroscience

MicroRNA in disease regulationNeuroscience and Neuropharmacology Research

Cited by 12